Cronos Group Inc. (CRON) shareholders
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/307% below fair value
$3.38−0.03 (-0.88%)
Close on Nov 13, 2026Market cap $1.25BP/E 19.9Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
12.9%
47M of 368M shares
Institutional holders
194
26 new, 20 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Altria Group, Inc. Joint filing with Altria Summit LLC (41.00%), Maple Holdco (Bermuda) Ltd. (41.00%) and 1 more | 156,573,537 | 41.00% | 13D (active) amendment | Apr 25, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CRON | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| D. E. Shaw & Co., Inc. | 8,840,503 | 2.40% | $24.55M | +1,222,276 | 0.01% |
| Chescapmanager LLC | 7,942,737 | 2.16% | $22.08M | – | 1.88% |
| Toroso Investments, LLC | 3,767,849 | 1.02% | $10.47M | −259,043 | 0.02% |
| Dimensional Fund Advisors LP | 3,048,254 | 0.83% | $8.47M | +369,203 | 0.00% |
| Arrowstreet Capital, Limited Partnership | 1,992,855 | 0.54% | $5.53M | New | 0.00% |
| Renaissance Technologies LLC | 1,742,149 | 0.47% | $4.84M | −267,400 | 0.01% |
| Mackenzie Financial Corp | 1,597,039 | 0.43% | $6.26M | New | 0.01% |
| Cibc World Market Inc. | 1,383,299 | 0.38% | $3.82M | +36,479 | 0.01% |
| MMCAP International Inc. SPC | 999,490 | 0.27% | $2.78M | – | 0.24% |
| Quinn Opportunity Partners LLC | 969,033 | 0.26% | $2.69M | – | 0.12% |
| Citadel Advisors LLC | 950,985 | 0.26% | $2.64M | +586,328 | 0.00% |
| Pillsbury Lake Capital LLC | 810,163 | 0.22% | $2.25M | −3,412,841 | 0.61% |
| Prelude Capital Management, LLC | 810,163 | 0.22% | $2.25M | −689,837 | 0.16% |
| Susquehanna International Group, Llp | 756,075 | 0.21% | $2.10M | −504,392 | 0.00% |
| Silver Oak Securities, Incorporated | 655,972 | 0.18% | $1.82M | +19,700 | 0.11% |
| Qube Research & Technologies Ltd | 641,680 | 0.17% | $1.78M | −203,438 | 0.00% |
| Jane Street Group, LLC | 607,299 | 0.16% | $1.69M | −162,876 | 0.00% |
| Geode Capital Management, LLC | 577,274 | 0.16% | $1.60M | +25,638 | 0.00% |
| Goldman Sachs Group Inc | 543,236 | 0.15% | $1.51M | +22,274 | 0.00% |
| UBS Group AG | 508,976 | 0.14% | $1.41M | +13,398 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 194 | 47M | 12.9% | 26 / 42 | 42 / 20 | 7M | 8M |
| Q1 2026 | 191 | 49M | 13.3% | 23 / 36 | 50 / 26 | 8M | 11M |
| Q4 2025 | 199 | 52M | 14.1% | 36 / 37 | 52 / 23 | 11M | 10M |
| Q3 2025 | 188 | 51M | 13.8% | 33 / 47 | 36 / 21 | 14M | 12M |
| Q2 2025 | 178 | 49M | 13.4% | 30 / 45 | 34 / 17 | 12M | 7M |
| Q1 2025 | 166 | 44M | 12.0% | 17 / 34 | 37 / 32 | 14M | 13M |
| Q4 2024 | 185 | 43M | 11.8% | 36 / 38 | 45 / 23 | 5M | 2M |
| Q3 2024 | 178 | 42M | 11.3% | 24 / 36 | 46 / 27 | 3M | 5M |
| Q2 2024 | 181 | 43M | 11.8% | 25 / 47 | 37 / 18 | 9M | 9M |
| Q1 2024 | 178 | 45M | 12.1% | 32 / 36 | 37 / 23 | 15M | 4M |
| Q4 2023 | 170 | 34M | 9.1% | 31 / 37 | 36 / 21 | 6M | 2M |
| Q3 2023 | 161 | 30M | 8.2% | 27 / 43 | 32 / 15 | 6M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
30 funds held CRON in Q2 2026, 30% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CRON | Value | % of fund | As of |
|---|---|---|---|---|---|
| Amplify Alternative Harvest ETF | 3,638,889 | 0.99% | $10.12M | 9.13% | Jun 30, 2026 |
| International Core Equity 2 Portfolio | 863,846 | 0.23% | $2.44M | 0.01% | Jul 31, 2026 |
| The Canadian Small Company Series | 756,600 | 0.21% | $2.14M | 0.11% | Jul 31, 2026 |
| iShares Core MSCI Total International Stock ETF | 664,585 | 0.18% | $1.34M | 0.00% | Jul 31, 2026 |
| AdvisorShares Pure Cannabis ETF | 482,394 | 0.13% | $1.34M | 3.91% | Jun 30, 2026 |
| USA Mutuals Vice Fund | 480,000 | 0.13% | $1.33M | 2.61% | Jun 30, 2026 |
| Dimensional International Small Cap ETF | 430,309 | 0.12% | $1.22M | 0.02% | Jul 31, 2026 |
| Dimensional International Core Equity 2 ETF | 379,299 | 0.10% | $1.07M | 0.01% | Jul 31, 2026 |
| iShares Core MSCI International Developed Markets ETF | 353,992 | 0.10% | $711.52K | 0.00% | Jul 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 226,947 | 0.06% | $644.53K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index ETF | 216,657 | 0.06% | $615.31K | 0.01% | May 31, 2026 |
| Dimensional World ex. U.S. Core Equity 2 ETF | 207,415 | 0.06% | $586.98K | 0.00% | Jul 31, 2026 |
| International Vector Equity Portfolio | 203,179 | 0.06% | $575.00K | 0.01% | Jul 31, 2026 |
| The Canadian Small Company Series | 161,112 | 0.04% | $323.83K | 0.02% | Jul 31, 2026 |
| Dimensional International Core Equity Market ETF | 159,314 | 0.04% | $319.76K | 0.00% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Michael Ryan Gorenstein | See remarks below, Director | 13,213,017 | 3.59% | Mar 17, 2026 |
| Adam Wagner | See remarks | 124,229 | 0.03% | Nov 12, 2026 |
| Christopher Martens | General Manager | – | – | Oct 20, 2026 |
| Terrence Gregory Joseph Doucet | See Remarks | 110,588 | 0.03% | May 14, 2026 |
| Shannon Buggy | See Remarks | 178,322 | 0.05% | May 14, 2026 |
| Jared Matthew Kenost | See Remarks | 46,675 | 0.01% | May 14, 2026 |
| Arye Weigensberg | See Remarks | 211,555 | 0.06% | May 12, 2026 |
| Anna Shlimak | See Remarks | 358,595 | 0.10% | Mar 20, 2026 |
| Jeffrey David Jacobson | Chief Growth Officer | 484,681 | 0.13% | Mar 17, 2026 |
| Lloyd Anderson Wilson | VP, Controller | 10,500 | 0.00% | Aug 11, 2025 |
| James Holm | Chief Financial Officer | 203,387 | 0.06% | Mar 18, 2025 |
| James Andrew McGinness III | VP, Controller | 17,543 | 0.00% | Mar 14, 2025 |
| James Daniel Rudyk | Director | 36,237 | 0.01% | Aug 7, 2026 |
| Jason Marc Adler | Director | 10,657,451 | 2.89% | Aug 7, 2026 |
| Murray R. Garnick | Director | 0 | – | Aug 7, 2026 |
| Darren Chester Broughton | Director | – | – | Jun 30, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Adam Wagner See remarks | Nov 7, 2026 | Option exercise | +20,242 | – | – | 124,229 |
| Jared Matthew Kenost See Remarks | May 12, 2026 | Option exercise | +9,412 | – | – | 46,675 |
| Jared Matthew Kenost See Remarks | May 12, 2026 | Tax withholding | −3,701 | $2.75 | $10.18K | 42,974 |
| Adam Wagner See remarks | May 12, 2026 | Option exercise | +10,367 | – | – | 103,987 |
| Terrence Gregory Joseph Doucet See Remarks | May 12, 2026 | Tax withholding | −5,199 | $3.75 | $19.50K | 110,588 |
| Terrence Gregory Joseph Doucet See Remarks | May 12, 2026 | Option exercise | +10,597 | – | – | 115,787 |
| Shannon Buggy See Remarks | May 12, 2026 | Tax withholding | −9,179 | $2.75 | $25.24K | 178,322 |
| Shannon Buggy See Remarks | May 12, 2026 | Option exercise | +20,622 | – | – | 187,501 |
| Adam Wagner See remarks | May 10, 2026 | Option exercise | +10,407 | – | – | 93,620 |
| Adam Wagner See remarks | May 10, 2026 | Option exercise | +10,063 | – | – | 83,213 |
| Jared Matthew Kenost See Remarks | May 10, 2026 | Option exercise | +7,535 | – | – | 36,923 |
| Jared Matthew Kenost See Remarks | May 10, 2026 | Tax withholding | −1,878 | $2.54 | $4.77K | 37,263 |
| Jared Matthew Kenost See Remarks | May 10, 2026 | Option exercise | +5,114 | – | – | 39,141 |
| Jared Matthew Kenost See Remarks | May 10, 2026 | Tax withholding | −2,896 | $2.54 | $7.36K | 34,027 |
| Arye Weigensberg See Remarks | May 10, 2026 | Option exercise | +3,118 | – | – | 211,555 |
| Anna Shlimak See Remarks | Mar 19, 2026 | Tax withholding | −9,767 | $2.54 | $24.81K | 358,595 |
| Anna Shlimak See Remarks | Mar 19, 2026 | Option exercise | +28,429 | – | – | 368,362 |
| Shannon Buggy See Remarks | Mar 15, 2026 | Option exercise | +20,938 | – | – | 176,081 |
| Shannon Buggy See Remarks | Mar 15, 2026 | Tax withholding | −9,202 | $2.50 | $23.01K | 166,879 |
| Anna Shlimak See Remarks | Mar 15, 2026 | Tax withholding | −16,354 | $2.50 | $40.89K | 339,933 |
| Anna Shlimak See Remarks | Mar 15, 2026 | Option exercise | +45,226 | – | – | 356,287 |
| Arye Weigensberg See Remarks | Mar 15, 2026 | Option exercise | +24,236 | – | – | 208,437 |
| Jeffrey David Jacobson Chief Growth Officer | Mar 15, 2026 | Tax withholding | −22,552 | $2.50 | $56.38K | 484,681 |
| Jeffrey David Jacobson Chief Growth Officer | Mar 15, 2026 | Option exercise | +59,191 | – | – | 507,233 |
| Michael Ryan Gorenstein See remarks below, Director | Mar 15, 2026 | Tax withholding | −127,706 | $2.50 | $319.27K | 13,213,017 |
| Michael Ryan Gorenstein See remarks below, Director | Mar 15, 2026 | Option exercise | +324,540 | – | – | 13,340,723 |
| Terrence Gregory Joseph Doucet See Remarks | Mar 15, 2026 | Option exercise | +23,897 | – | – | 117,466 |
| Terrence Gregory Joseph Doucet See Remarks | Mar 15, 2026 | Tax withholding | −12,276 | $3.44 | $42.23K | 105,190 |
| Jeffrey David Jacobson Chief Growth Officer | Mar 12, 2026 | Tax withholding | −24,926 | $2.56 | $63.81K | 448,042 |
| Jeffrey David Jacobson Chief Growth Officer | Mar 12, 2026 | Option exercise | +65,179 | – | – | 472,968 |
| Michael Ryan Gorenstein See remarks below, Director | Mar 12, 2026 | Option exercise | +339,879 | – | – | 13,149,174 |
| Michael Ryan Gorenstein See remarks below, Director | Mar 12, 2026 | Tax withholding | −132,991 | $2.56 | $340.46K | 13,016,183 |
| Anna Shlimak See Remarks | Mar 12, 2026 | Option exercise | +47,368 | – | – | 328,291 |
| Anna Shlimak See Remarks | Mar 12, 2026 | Tax withholding | −17,230 | $2.56 | $44.11K | 311,061 |
| Arye Weigensberg See Remarks | Mar 12, 2026 | Option exercise | +26,825 | – | – | 184,201 |
| Adam Wagner See remarks | Mar 12, 2026 | Option exercise | +15,715 | – | – | 73,150 |
| Terrence Gregory Joseph Doucet See Remarks | Mar 12, 2026 | Option exercise | +23,809 | – | – | 105,804 |
| Terrence Gregory Joseph Doucet See Remarks | Mar 12, 2026 | Tax withholding | −12,235 | $3.48 | $42.58K | 93,569 |
| Shannon Buggy See Remarks | Mar 12, 2026 | Option exercise | +21,930 | – | – | 164,871 |
| Shannon Buggy See Remarks | Mar 12, 2026 | Tax withholding | −9,728 | $2.56 | $24.90K | 155,143 |
| Anna Shlimak See Remarks | Mar 8, 2026 | Tax withholding | −18,943 | $2.57 | $48.68K | 280,923 |
| Anna Shlimak See Remarks | Mar 8, 2026 | Option exercise | +45,680 | – | – | 299,866 |
| Jeffrey David Jacobson Chief Growth Officer | Mar 8, 2026 | Tax withholding | −25,605 | $2.57 | $65.80K | 407,789 |
| Jeffrey David Jacobson Chief Growth Officer | Mar 8, 2026 | Option exercise | +60,536 | – | – | 433,394 |
| Arye Weigensberg See Remarks | Mar 8, 2026 | Option exercise | +21,484 | – | – | 157,376 |
| Terrence Gregory Joseph Doucet See Remarks | Mar 8, 2026 | Tax withholding | −12,580 | $3.51 | $44.16K | 81,995 |
| Terrence Gregory Joseph Doucet See Remarks | Mar 8, 2026 | Option exercise | +24,434 | – | – | 94,575 |
| Shannon Buggy See Remarks | Mar 8, 2026 | Option exercise | +25,378 | – | – | 155,859 |
| Shannon Buggy See Remarks | Mar 8, 2026 | Option exercise | +21,148 | – | – | 141,007 |
| Shannon Buggy See Remarks | Mar 8, 2026 | Tax withholding | −12,918 | $2.57 | $33.20K | 142,941 |
| Shannon Buggy See Remarks | Mar 8, 2026 | Tax withholding | −10,526 | $2.57 | $27.05K | 130,481 |
| Michael Ryan Gorenstein See remarks below, Director | Mar 8, 2026 | Option exercise | +327,801 | – | – | 12,938,213 |
| Michael Ryan Gorenstein See remarks below, Director | Mar 8, 2026 | Tax withholding | −128,918 | $2.57 | $331.32K | 12,809,295 |
| Arye Weigensberg See Remarks | Dec 13, 2025 | Option exercise | +6,423 | – | – | 135,892 |
| Michael Ryan Gorenstein See remarks below, Director | Dec 13, 2025 | Option exercise | +166,642 | – | – | 12,675,414 |
| Michael Ryan Gorenstein See remarks below, Director | Dec 13, 2025 | Tax withholding | −65,002 | $3.27 | $212.56K | 12,610,412 |
| Arye Weigensberg See Remarks | May 12, 2025 | Option exercise | +9,014 | – | – | 129,469 |
| Terrence Gregory Joseph Doucet See Remarks | May 12, 2025 | Option exercise | +12,876 | – | – | 76,407 |
| Terrence Gregory Joseph Doucet See Remarks | May 12, 2025 | Tax withholding | −6,266 | $3.86 | $24.19K | 70,141 |
| Adam Wagner SVP, Head of Cronos Israel | May 12, 2025 | Option exercise | +6,276 | – | – | 57,435 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
1.21%
4M shares short
Days to cover
4.9
At 1M shares a day
Change since last report
+4.9%
From 4M shares
Short volume, 20 days
31.9%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cronos's stock actually held short. Settlement fails (shares not delivered on time) peaked at 33,088 shares on Aug 31, 2026 over the last 90 days.
See a number that looks wrong?